Chairman of the Board
Kent Swanson was with Accenture for over 32 years, retiring from the firm in 2001 as a Senior Partner. He held global leadership and management positions in a wide range of industries and geographies. From 2001 to 2008, he was the Board Chair of ALN Medical Management; providing outsourced services for clinic-based physician practices. Also from 2001 to 2008, he was Board Chair for Boys Hope Girls Hope of Colorado, a charitable organization providing a home and scholarship education for disadvantaged children with significant capabilities and promise. From 2002 to 2009, he was a Board member, Audit Committee member and Compensation Committee Chair for MPC Computers. Mr. Swanson graduated with distinction from the University of Minnesota earning an M.S. in Business and received an M.B.A. from the University of Chicago in 1969.
John Deedrick is an experienced senior executive with 15 years’ experience in healthcare venture capital and business consulting. Mr. Deedrick also has 12 years of experience in the high tech defense industry. He has served as a corporate venture capitalist for Mayo Clinic and a Founder and General Partner for Accuitive Medical Ventures. Mr. Deedrick also serves as President and CEO of CHIP Solutions and is Founder and Chairman of GreatDeeds, a Minnesota non-profit organization. Mr. Deedrick has served on the board of numerous early-stage healthcare companies over the last 15 years. Mr. Deedrick received his undergraduate degree from Northwestern College (Roseville, MN) and his MBA from St. Thomas University (St. Paul, MN).
David E. Goodman, MD, MSE
Trained in both biomedical engineering and medicine, Dr. Goodman has devoted his career to improving health through the development and integration of innovative technologies into clinical practice. Dr. Goodman currently serves as Co-Founder and Chief Medical Officer of FirstVitals Health & Wellness, a technology-enabled service company focused on preventing complications such as foot ulcers and lower extremity amputations in people with diabetes. He also serves on the board of directors of NEUROMetrix (Nasdaq: NURO), and has served as a director of Sound Surgical Technologies LLC, acquired by Solta Medical (Nasdaq:SLTM) in 2013. Dr. Goodman holds a BAS in applied science and bioengineering and an MSE in bioengineering from the University of Pennsylvania, and received an MD cum laude from Harvard Medical School and the Harvard-M.I.T. Division of Health Sciences and Technology. He holds 18 issued and 4 pending US patents and maintains clinical practices in California and Hawaii.
Michael Lopach is a certified public accountant with over 40 years of accounting experience. Mr. Lopach spent 27 years of his career with Galusha, Higgins, Galusha & Co., the largest privately held accounting firm in Montana and northern Idaho, where he served as president and CEO. In 1999, Mr. Lopach founded Lopach & Carparelli PC, an accounting firm that focuses on medical practitioners. Mr. Lopach received his MBA from the University of Notre Dame. Mr. Lopach serves as chairman of the Board’s Audit Committee.
John Wickwire is an attorney and founding shareholder of Wickwire Gavin, P.C., a national construction law firm which merged with Akerman Senterfitt, one of the top 100 law firms in the United States. Mr. Wickwire served as lead counsel on major infrastructure litigation and alternative dispute resolutions, both domestically and internationally, throughout his 35 year career, and was the founding fellow of the American College of Construction Lawyers. Mr. Wickwire also served as the founding chairman of the College of Scheduling, an organization dedicated to advancing the techniques, practice and profession of project scheduling, and has authored several books and articles on construction and public contract law, including Construction Management: Law and Practice and The Construction Subcontracting Manual: Practice Guide with Forms. Mr. Wickwire currently serves on the advisory board for Crunchies Food Company. Mr. Wickwire is a graduate of the University of Maryland and Georgetown University Law Center. Mr. Wickwire serves as chairman of the Nominations and Corporate Governance Committee.
Mr. Goldberger has more than 25 years of experience in the medical technology and device industry. Prior to joining Bacterin, Dan was the CEO of Sound Surgical Technologies from April 2007 through its merger with Solta Medical (Nasdaq SLTM) in February 2013. During his career, he has held several executive leadership positions within the medical device industry, as the CEO and Director of Xcorporeal Inc. and President of Medical Group of OSI Systems. He holds a BS in Mechanical Engineering from the Massachusetts Institute of Technology and an MS in Mechanical Engineering from Stanford University. Dan is a named inventor on more than 60 U.S. patents.
David Kirschman, M.D.
Dr. Kirschman is an inventor and entrepreneur with an extensive background in the clinical and corporate aspects of the medical device industry. He completed training in neurosurgery specializing in complex spinal surgery. Dr. Kirschman has 36 issued and 21 patents pending for a wide range of spinal devices. Dr. Kirschman is the Executive Vice President and Chief Scientific Officer of Xtant Medical, and President of the X-spine subsidiary. He was the CEO of X-spine Systems, Inc. from 2003 until the combination creating Xtant Medical in 2015. Dr. Kirschman received his BS in Biological Science cum laude from Colorado State University and M.D. from the University of Colorado School of Medicine.